Modern Action logo
IssuesBillsBriefingNewsletterAbout
Donate
Donate
Modern Action

Navigation

Menu

01HomeFront page→02IssuesActive issue pages→03BillsLegislation index→04BriefingDaily context→05NewsletterWeekly Watchlist→06AboutMission and team→07DonateSupport the work→

Account

Sign In→Get Started→
Modern Action

Find the bills behind the news, understand what Congress can do, and contact your representatives with a specific message.

Platform

  • Contact Congress
  • Write to Congress
  • Browse Bills
  • Track Bills

Resources

  • Find My Representatives
  • Contact My Representatives
  • How to Contact Representatives
  • Does Contacting Congress Work?
  • Newsletter

Support

  • About
  • Contact Us
  • Press
  • Accessibility

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Accessibility

Stay informed about legislation

Get weekly updates on important bills and how to take action.

© 2026 Modern Action. All rights reserved.

Made with ❤️ for democracy
All systems operational

Contact Congress about S. 3122: Better FDA Act of 2025

Food companies would have to notify the FDA before using many ingredients they claim are safe. The FDA would keep a public list and could review listed ingredients later if safety questions arise.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Better FDA Act of 2025 is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Latest action on S. 3122: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who this affects: This bill mainly affects food makers and ingredient suppliers that use GRAS substances. They would have new FDA notice duties and deadlines. It also affects the FDA, which would have to build the public list and run new reviews. Consumers, researchers, and state regulators could get more public information about substances used in food.

Why this matters: Right now, companies can make many GRAS safety decisions without having to tell the FDA. This bill would give the FDA a required notice system and a public list, so the agency and the public can better see which substances are being used and why. It could make food ingredient oversight more open, but it could also add costs and deadlines for companies. The final effect would depend on how the FDA writes the rules and how many substances it reviews.

Key provisions in S. 3122

  • After two years, a GRAS substance would need to be on the FDA public list or still under FDA review. If not, food using it would count as unsafe under current food safety rules.
  • Companies would have two years to report GRAS substances they already use. For new GRAS substances, they would have to notify the FDA 120 days before using them in food sold across state lines.
  • The FDA would have two years to write the rules. Those rules would create the process and the public list for GRAS food substances.
  • The FDA would have 180 days after getting a GRAS notice to act. It could add the substance to the list or make an early decision to keep it off. If the FDA misses the deadline, the substance is listed automatically.
  • If the FDA first rejects or later removes a GRAS substance, users would have 180 days to choose a next step. They could ask for another review with more data, file a food-additive request, or propose a plan to stop using it.

How Modern Action helps you take action on S. 3122

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 3122

What is S. 3122?
Food companies would have to notify the FDA before using many ingredients they claim are safe. The FDA would keep a public list and could review listed ingredients later if safety questions arise.
How do I support or oppose S. 3122?
Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
Who should I contact about S. 3122?
Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
Can Modern Action explain S. 3122 before I act?
Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.